DD vs TXMD · P/E 127, rev $12.39B vs rev $1.8M
Dupont De Nemours Inc (DD) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the DD and TXMD stock pages for the full models.
Not investment advice.